Literature DB >> 19541928

High fat diet induced hepatic steatosis establishes a permissive microenvironment for colorectal metastases and promotes primary dysplasia in a murine model.

Michael Nathan VanSaun1, In Kyu Lee, Mary Kay Washington, Lynn Matrisian, David Lee Gorden.   

Abstract

Non-alcoholic fatty liver disease (NAFLD), which includes steatosis and its progression to non-alcoholic steatohepatitis, is a liver disorder of increasing clinical significance. Here we characterize a murine model of high fat diet-induced NAFLD with progression from liver steatosis to histological features compatible with steatohepatitis and more advanced stages of NAFLD in humans, including chronic portal inflammation, pericellular and bridging fibrosis, Mallory body formation, and bile ductular reaction. Chronic changes induced by the prolonged consumption of a high-fat diet alone culminate in the development of primary liver dysplasias. Importantly, we extend these studies to demonstrate that even the early stages of uncomplicated steatosis provide a permissive microenvironment for the growth of colon cancer cells that are metastatic to the liver. High fat diet-induced steatosis, coupled with a splenic injection model of experimental liver metastasis using syngeneic MC38 colon cancer cells, resulted in an increased number of secondary tumor nodules and metastatic burden in steatotic livers. Metastatic nodules were associated with focal peritumoral areas of infiltrating inflammatory cells and associated apoptotic cell populations. These results suggest that the modulation of specific host factors in the steatotic liver contributes to tumor progression in the microenvironment of NAFLD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19541928      PMCID: PMC2708821          DOI: 10.2353/ajpath.2009.080703

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  42 in total

1.  Genetic obesity and neoplasia.

Authors:  W E HESTON; G VLAHAKIS
Journal:  J Natl Cancer Inst       Date:  1962-07       Impact factor: 13.506

2.  Proposal for a histological scoring and grading system for non-alcoholic fatty liver disease.

Authors:  Michel Henry Mendler; Gary Kanel; Sugantha Govindarajan
Journal:  Liver Int       Date:  2005-04       Impact factor: 5.828

3.  Ubiquitin is present on the cytokeratin intermediate filaments and Mallory bodies of hepatocytes.

Authors:  M Ohta; N Marceau; G Perry; V Manetto; P Gambetti; L Autilio-Gambetti; J Metuzals; H Kawahara; M Cadrin; S W French
Journal:  Lab Invest       Date:  1988-12       Impact factor: 5.662

Review 4.  Animal models of steatosis.

Authors:  A Koteish; A M Diehl
Journal:  Semin Liver Dis       Date:  2001       Impact factor: 6.115

Review 5.  Obesity and hepatocellular carcinoma.

Authors:  Stephen H Caldwell; Deborah M Crespo; Hyon Scott Kang; Abdullah M S Al-Osaimi
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

6.  Hypoadiponectinemia accelerates hepatic tumor formation in a nonalcoholic steatohepatitis mouse model.

Authors:  Yoshihiro Kamada; Hitoshi Matsumoto; Shinji Tamura; Juichi Fukushima; Shinichi Kiso; Koji Fukui; Takumi Igura; Norikazu Maeda; Shinji Kihara; Tohru Funahashi; Yuji Matsuzawa; Iichiro Shimomura; Norio Hayashi
Journal:  J Hepatol       Date:  2007-04-09       Impact factor: 25.083

Review 7.  Diet and nonalcoholic fatty liver disease.

Authors:  Ronald P Mensink; Jogchum Plat; Patrick Schrauwen
Journal:  Curr Opin Lipidol       Date:  2008-02       Impact factor: 4.776

Review 8.  Hepatic NKT cells: friend or foe?

Authors:  Mark G Swain
Journal:  Clin Sci (Lond)       Date:  2008-04       Impact factor: 6.124

9.  Is obesity an independent prognosis factor in woman breast cancer?

Authors:  Bilal Majed; Thierry Moreau; Kamel Senouci; Rémi J Salmon; Alain Fourquet; Bernard Asselain
Journal:  Breast Cancer Res Treat       Date:  2007-10-16       Impact factor: 4.872

10.  Development of hepatocellular adenomas and carcinomas associated with fibrosis in C57BL/6J male mice given a choline-deficient, L-amino acid-defined diet.

Authors:  Ayumi Denda; Wakashi Kitayama; Hideki Kishida; Nao Murata; Masahiro Tsutsumi; Toshifumi Tsujiuchi; Dai Nakae; Yoichi Konishi
Journal:  Jpn J Cancer Res       Date:  2002-02
View more
  49 in total

1.  A low carbohydrate, high protein diet combined with celecoxib markedly reduces metastasis.

Authors:  Victor W Ho; Melisa J Hamilton; Ngoc-Ha Thi Dang; Brian E Hsu; Hans H Adomat; Emma S Guns; Aalim Weljie; Ismael Samudio; Kevin L Bennewith; Gerald Krystal
Journal:  Carcinogenesis       Date:  2014-07-14       Impact factor: 4.944

2.  Recent advances in colorectal cancer research: the microenvironment impact.

Authors:  Anne-Laure Pin; François Houle; Jacques Huot
Journal:  Cancer Microenviron       Date:  2011-08

3.  CAPS1 promotes colorectal cancer metastasis via Snail mediated epithelial mesenchymal transformation.

Authors:  Guang-Xi Zhao; Ying-Ying Xu; Shu-Qiang Weng; Si Zhang; Ying Chen; Xi-Zhong Shen; Ling Dong; She Chen
Journal:  Oncogene       Date:  2019-02-11       Impact factor: 9.867

Review 4.  Creatine metabolism: energy homeostasis, immunity and cancer biology.

Authors:  Lawrence Kazak; Paul Cohen
Journal:  Nat Rev Endocrinol       Date:  2020-06-03       Impact factor: 43.330

5.  Metastatic colorectal cancer outcome and fatty liver disease.

Authors:  Antoine Brouquet; Bernard Nordlinger
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-04-09       Impact factor: 46.802

Review 6.  Role of xenobiotics in the induction and progression of fatty liver disease.

Authors:  James E Klaunig; Xilin Li; Zemin Wang
Journal:  Toxicol Res (Camb)       Date:  2018-05-18       Impact factor: 3.524

7.  Association of nonalcoholic fatty liver disease and liver cancer.

Authors:  Perla Oliveira Schulz; Fabio Gonçalves Ferreira; Maria de Fátima Araújo Nascimento; Andrea Vieira; Mauricio Alves Ribeiro; André Ibrahim David; Luiz Arnaldo Szutan
Journal:  World J Gastroenterol       Date:  2015-01-21       Impact factor: 5.742

8.  Short-term treatment with metformin reduces hepatic lipid accumulation but induces liver inflammation in obese mice.

Authors:  Alexandre Abilio de Souza Teixeira; Camila O Souza; Luana A Biondo; Loreana Sanches Silveira; Edson A Lima; Helena A Batatinha; Adriane Pereira Araujo; Michele Joana Alves; Sandro Massao Hirabara; Rui Curi; José Cesar Rosa Neto
Journal:  Inflammopharmacology       Date:  2018-02-15       Impact factor: 4.473

9.  Non-alcoholic fatty liver disease and colorectal cancer survival.

Authors:  Kana Wu; Mike Z Zhai; Erin K Weltzien; Elizabeth M Cespedes Feliciano; Jeffrey A Meyerhardt; Edward Giovannucci; Bette J Caan
Journal:  Cancer Causes Control       Date:  2018-11-15       Impact factor: 2.506

10.  An optical nanoreporter of endolysosomal lipid accumulation reveals enduring effects of diet on hepatic macrophages in vivo.

Authors:  Thomas V Galassi; Prakrit V Jena; Janki Shah; Geyou Ao; Elizabeth Molitor; Yaron Bram; Angela Frankel; Jiwoon Park; Jose Jessurun; Daniel S Ory; Adriana Haimovitz-Friedman; Daniel Roxbury; Jeetain Mittal; Ming Zheng; Robert E Schwartz; Daniel A Heller
Journal:  Sci Transl Med       Date:  2018-10-03       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.